Xyzal: Advanced 24-Hour Relief from Allergic Rhinitis and Chronic Idiopathic Urticaria
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.15 | $43.00 (0%) | 🛒 Add to cart |
| 30 | $1.89 | $64.50 $56.76 (12%) | 🛒 Add to cart |
| 60 | $1.63 | $129.00 $98.04 (24%) | 🛒 Add to cart |
| 90 | $1.38 | $193.50 $123.84 (36%) | 🛒 Add to cart |
| 120 | $1.12 | $258.00 $134.16 (48%) | 🛒 Add to cart |
| 180 | $0.86 | $387.00 $154.80 (60%) | 🛒 Add to cart |
| 270 | $0.69 | $580.50 $185.76 (68%) | 🛒 Add to cart |
| 360 | $0.60
Best per pill | $774.00 $216.72 (72%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.67 | $40.42 (0%) | 🛒 Add to cart |
| 90 | $0.54 | $60.63 $49.02 (19%) | 🛒 Add to cart |
| 120 | $0.46 | $80.84 $55.04 (32%) | 🛒 Add to cart |
| 180 | $0.41 | $121.26 $73.10 (40%) | 🛒 Add to cart |
| 270 | $0.34 | $181.89 $92.88 (49%) | 🛒 Add to cart |
| 360 | $0.30
Best per pill | $242.52 $108.36 (55%) | 🛒 Add to cart |
Synonyms | |||
Xyzal (levocetirizine dihydrochloride) is a next-generation, prescription-strength antihistamine designed for superior management of allergic conditions. As the active R-enantiomer of cetirizine, it offers targeted histamine H1-receptor blockade with a refined pharmacokinetic profile, resulting in potent, long-lasting symptom control with a low incidence of sedative effects. This medication is indicated for the relief of symptoms associated with perennial and seasonal allergic rhinitis and for the treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. Its clinical profile makes it a first-line choice for healthcare providers seeking effective and well-tolerated allergy management.
Features
- Active Pharmaceutical Ingredient: Levocetirizine dihydrochloride 5 mg per tablet (2.5 mg/5 mL for oral solution)
- Pharmacological Class: Second-generation, piperazine-derivative antihistamine, H1-receptor inverse agonist
- Dosage Form: Film-coated tablets and clear, colorless, banana-grape flavored oral solution
- Dosing Frequency: Once-daily, 24-hour efficacy
- Rapid Onset: Symptom relief can begin within one hour of administration
- Bioavailability: High and not significantly affected by food
- Metabolism: Minimally metabolized in the liver; primarily excreted renally as unchanged drug
- Half-life: Approximately 8-9 hours, supporting once-daily dosing
Benefits
- Provides Full 24-Hour Symptom Control: A single daily dose effectively suppresses the histamine response throughout the day and night, reducing sneezing, rhinorrhea, nasal congestion, itchy nose/palate/throat, and ocular symptoms like itchy, watery, red eyes.
- Promotes Daytime Alertness and Nighttime Rest: Its high specificity for peripheral H1-receptors and minimal penetration of the blood-brain barrier significantly reduce the risk of sedation and cognitive impairment compared to first-generation antihistamines, allowing for normal daily function and improved sleep quality.
- Offers Rapid and Potent Relief: Clinical studies demonstrate a fast onset of action, with many patients experiencing noticeable symptom improvement within 60 minutes of taking the medication, making it effective for both planned and acute allergy exposure.
- Simplifies Treatment Regimens: The once-daily dosing schedule enhances patient adherence and convenience, reducing the chance of missed doses and ensuring consistent therapeutic coverage.
- Suitable for a Wide Patient Demographic: Available in both tablet and pleasant-tasting liquid form, it is approved for use in children as young as 6 months, adolescents, and adults, including the elderly with normal renal function.
- Non-Addictive and Non-Habit Forming: As a non-scheduled antihistamine, it does not carry a risk of dependence or abuse, supporting its use for long-term chronic condition management.
Common use
Xyzal is primarily prescribed for the management of two key conditions. First, for allergic rhinitis, both seasonal (e.g., triggered by pollen from trees, grasses, and weeds) and perennial (e.g., triggered by indoor allergens like dust mites, pet dander, and mold spores). It alleviates the constellation of upper respiratory symptoms, including sneezing, runny nose, itchy nose and throat, and itchy, watery eyes. Second, it is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria (CIU), commonly known as hives of unknown cause. It works to reduce the severity of itching and the number and size of wheals (hives) in patients with this condition.
Dosage and direction
Dosing is based on age and renal function. It is recommended to be taken in the evening due to the potential for somnolence, although the incidence is low.
- Adults and Adolescents (12 years and older): 5 mg (one tablet or 10 mL oral solution) once daily.
- Children (6 to 11 years): 2.5 mg (half a tablet or 5 mL oral solution) once daily. Tablet should not be divided by weight; use oral solution for accurate dosing if 2.5 mg is required.
- Children (6 months to 5 years): 1.25 mg (2.5 mL oral solution) once daily. Use only the oral solution.
- Geriatric Patients & Renal Impairment: Dose adjustment is necessary. For patients with moderate renal impairment (creatinine clearance 30-49 mL/min), a dose of 2.5 mg once daily is recommended. For patients with severe renal impairment (creatinine clearance 10-29 mL/min), a dose of 2.5 mg every other day is recommended. It is not recommended for patients with end-stage renal disease (creatinine clearance < 10 mL/min).
- Hepatic Impairment: No dose adjustment is needed for hepatic impairment alone. However, adjustment is required for patients with both hepatic impairment and renal impairment.
- Administration: Can be taken with or without food. The tablet should be swallowed whole. The oral solution should be measured with a dedicated dosing spoon or syringe for accuracy.
Precautions
- Somnolence: While less sedating than older antihistamines, Xyzal may cause dose-related somnolence in some patients. Patients should be cautioned about engaging in potentially hazardous activities requiring mental alertness, such as driving or operating machinery, until they know how the drug affects them.
- Renal Impairment: Dosing must be adjusted in patients with moderate to severe renal impairment, as detailed above, due to the drug’s primary renal excretion.
- Concurrent Conditions: Use with caution in patients with predisposing factors for urinary retention (e.g., prostatic hyperplasia, bladder outlet obstruction) as antihistamines may aggravate this condition.
- Phenylketonurics: The oral solution contains aspartame, a source of phenylalanine (a maximum of 1.04 mg per 5 mL dose). It should be used with caution in patients with phenylketonuria.
Contraindications
Xyzal is contraindicated in the following populations:
- Patients with a known hypersensitivity to levocetirizine, cetirizine, any of the inactive ingredients, or other hydroxyzine derivatives.
- Patients with end-stage renal disease (creatinine clearance < 10 mL/min).
- Patients on hemodialysis.
Possible side effect
Most side effects are mild to moderate and often transient. Common adverse reactions (≥2% and greater than placebo) include:
- Somnolence (drowsiness)
- Nasopharyngitis
- Pharyngitis
- Pyrexia (fever) - in children aged 6 months to 12 years
- Otitis media - in children aged 6 months to 12 years
- Diarrhea - in children aged 6 months to 12 years
- Vomiting - in children aged 6 months to 12 years
- Cough - in children aged 6 months to 12 years
- Fatigue
- Dry mouth Less common but more serious side effects require immediate medical attention. These include:
- Severe allergic reactions (anaphylaxis) presenting as difficulty breathing, swelling of the face/tongue/throat, severe dizziness, or hives.
- Convulsions or seizures.
- Palpitations or tachycardia (fast heart rate).
Drug interaction
Formal drug-drug interaction studies have shown no clinically relevant interactions with pseudoephedrine, ketoconazole, azithromycin, or theophylline. However, theoretical interactions and precautions exist:
- CNS Depressants: Concomitant use with other drugs that cause CNS depression (e.g., alcohol, benzodiazepines, barbiturates, opioid analgesics, antipsychotics, other sedating antihistamines, antidepressant drugs) may potentiate the sedative effects of Xyzal. Patients should be monitored for an additive effect on CNS depression.
- Ritonavir: The potential for an interaction exists, though it is not expected to be clinically relevant at recommended doses. Caution is advised.
- Theophylline: A small decrease in the clearance of levocetirizine (16%) was observed, which is not considered clinically significant.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Do not take a double dose to make up for a missed one.
Overdose
In the event of an overdose, signs and symptoms are primarily related to CNS effects or may be consistent with the known side effect profile of the drug. Symptoms may include drowsiness, agitation, restlessness, and in children initially agitation and restlessness followed by drowsiness. There is no known specific antidote for levocetirizine overdose. Treatment should consist of general supportive measures, including gastric lavage within one hour of ingestion and monitoring of vital signs. Levocetirizine is not effectively removed by dialysis.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F and 86°F).
- Keep the bottle of oral solution tightly closed.
- Keep both tablets and oral solution in their original container to protect from light and moisture.
- Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
- Clinical Efficacy (4.8/5): “As an allergist, Xyzal is a cornerstone of my treatment plans. Its 24-hour efficacy and low sedation profile make it ideal for my patients who need to remain alert at work or school. The response in chronic idiopathic urticaria cases is particularly impressive.” – Dr. A. Reynolds, MD
- Patient Satisfaction (4.6/5): “After struggling with daytime drowsiness on other allergy meds, my doctor switched me to Xyzal. It’s been a game-changer. My spring allergies are completely controlled, and I have no grogginess. The once-daily dose is easy to remember.” – Sarah T.
- Pediatric Use (4.5/5): “My 4-year-old suffers from severe environmental allergies. The children’s liquid form is a lifesaver. It’s easy to administer, and he gets relief within an hour without becoming overly sleepy. It has drastically improved his quality of life, especially during playdates outside.” – Mark J.
- Tolerability (4.7/5): “I have a sensitive system and often experience side effects from medications. I was pleasantly surprised that Xyzal provided such effective relief for my year-round allergies with only minor initial drowsiness that faded after the first few doses.” – Linda K.